Cerity Partners LLC Has $11.22 Million Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

Cerity Partners LLC lessened its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 10.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 84,363 shares of the company’s stock after selling 9,638 shares during the quarter. Cerity Partners LLC owned 0.47% of Addus HomeCare worth $11,223,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Point72 Asset Management L.P. boosted its stake in Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after purchasing an additional 315,602 shares during the period. Millennium Management LLC boosted its position in shares of Addus HomeCare by 412.7% during the second quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock worth $36,739,000 after buying an additional 254,705 shares during the period. Boston Partners bought a new position in shares of Addus HomeCare during the first quarter worth about $12,215,000. Ghisallo Capital Management LLC bought a new position in shares of Addus HomeCare during the second quarter worth about $11,611,000. Finally, Principal Financial Group Inc. raised its position in Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after buying an additional 75,409 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. This represents a 12.93 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,500 shares of company stock valued at $1,668,265 over the last quarter. 4.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on ADUS. Stephens boosted their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Oppenheimer increased their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Macquarie reaffirmed an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. KeyCorp began coverage on Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price on the stock. Finally, TD Cowen boosted their price target on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Price Performance

ADUS stock opened at $124.41 on Wednesday. Addus HomeCare Co. has a fifty-two week low of $85.43 and a fifty-two week high of $136.12. The stock has a market capitalization of $2.26 billion, a price-to-earnings ratio of 28.47, a PEG ratio of 2.17 and a beta of 1.04. The business’s fifty day moving average price is $128.07 and its two-hundred day moving average price is $123.41.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same quarter in the previous year, the firm posted $1.03 EPS. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. Research analysts expect that Addus HomeCare Co. will post 4.58 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.